What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.42%Below 5Y avg (0.59%)
Annual Rate
CNY 0.23Paid annual
Payout Ratio
35.5%Sustainable
Last Ex-Dividend
May 14, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
120.40BCNY
17.88B · vs all stocks (USD)
Updated Aug 19, 2026
Trailing P/E
26.38x
Updated Aug 19, 2026
Revenue (TTM)
69.35BCNY
10.30B · vs all stocks (USD)
Updated Aug 19, 2026
Profit Margin
6.46%
Updated Aug 19, 2026
Beta
0.7070x
vs all stocks
Updated Aug 19, 2026
52-Week Change
15.25%
vs all stocks
Updated Aug 19, 2026
Market Capitalization
120.40BCNY
17.88B · vs all stocks (USD)
Updated Aug 19, 2026
Enterprise Value
140.17BCNY
20.82B · vs all stocks (USD)
Updated Aug 19, 2026
Trailing P/E
26.38x
Updated Aug 19, 2026
Forward P/E
12.22x
Updated Aug 19, 2026
Price to Sales (TTM)
1.74x
Updated Aug 19, 2026
Price to Book (MRQ)
2.62x
Updated Aug 19, 2026
Enterprise to Revenue
2.02x
Updated Aug 19, 2026
Enterprise to EBITDA
20.95x
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 25.6×.Updated Aug 19, 2026
Gross Margin
14.04%
Updated Aug 19, 2026
Profit Margin
6.46%
Updated Aug 19, 2026
Operating Margin
6.00%
Updated Aug 19, 2026
Return on Assets (TTM)
1.74%
Updated Aug 19, 2026
Return on Equity (TTM)
10.43%
Updated Aug 19, 2026
Revenue (TTM)
69.35BCNY
10.30B · vs all stocks (USD)
Updated Aug 19, 2026
Revenue per Share (TTM)
33.77CNYUpdated Aug 19, 2026
Quarterly Revenue Growth
61.60%
Updated Aug 19, 2026
Gross Profit (TTM)
10.50BCNY
1.56B · vs all stocks (USD)
Updated Aug 19, 2026
EBITDA (TTM)
5.48BCNY
813.21M · vs all stocks (USD)
Updated Aug 19, 2026
Net Income (TTM)
4.48BCNY
665.29M · vs all stocks (USD)
Updated Aug 19, 2026
Quarterly Earnings Growth (YoY)
31.30%
Updated Aug 19, 2026
Operating Cash Flow (TTM)
6.23BCNY
925.92M · vs all stocks (USD)
Updated Aug 19, 2026
Levered Free Cash Flow (TTM)
-6.13BCNY
-910.11M · vs all stocks (USD)
Updated Aug 19, 2026
Trailing Annual Dividend Rate
0.2338CNYUpdated Aug 19, 2026
Trailing Annual Dividend Yield
0.42%
vs all stocks
Updated Aug 19, 2026
5-Year Average Dividend Yield
0.59%
vs all stocks
Updated Aug 19, 2026
Payout Ratio
35.48%
Provider-reported. Trailing Annual Dividend Rate ÷ Diluted EPS (TTM) on this page gives 11.13%.Updated Aug 19, 2026
Minority Interest (Equity)
2.65BCNYFY2025 · Dec 31, 2025
Revenue
61.47BCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
51.53BCNYFY2025 · Dec 31, 2025
Gross Profit
9.94BCNYFY2025 · Dec 31, 2025
Operating Income
4.27BCNY
634.46M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
4.44BCNYFY2025 · Dec 31, 2025
Income Tax Expense
138.02MCNYFY2025 · Dec 31, 2025
Net Income
4.30BCNYFY2025 · Dec 31, 2025
EBIT
5.16BCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
8.74BCNYFY2025 · Dec 31, 2025
Research & Development
3.01BCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
711.11MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
245.77MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
104.76MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
716.12MCNYFY2025 · Dec 31, 2025
EPS (Basic)
2.02CNYFY2025 · Dec 31, 2025
EPS (Diluted)
1.96CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
2.05BSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
2.05BSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
4.30BCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
-167.84MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
-5.58BCNYFY2025 · Dec 31, 2025
Free Cash Flow
-16.00BCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
7.84BCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
4.30BCNYFY2025 · Dec 31, 2025
Other Non-cash Items
900.96MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-7.51BCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-3.28BCNYFY2025 · Dec 31, 2025
Capital Expenditures
-10.41BCNYFY2025 · Dec 31, 2025
Purchase of Investments
-264.27MCNYFY2025 · Dec 31, 2025
Sale of Investments
1.65BCNYFY2025 · Dec 31, 2025
Other Investing Activity
-3.59BCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-12.62BCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
15.31BCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-7.79BCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-2.28BCNYFY2025 · Dec 31, 2025
Other Financing Charges
-110.11MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
5.13BCNYFY2025 · Dec 31, 2025
Shares Outstanding
2.08BSharesUpdated Aug 19, 2026
Float Shares
1.31BSharesUpdated Aug 19, 2026
% Held by Insiders
37.16%
vs all stocks
Updated Aug 19, 2026
% Held by Institutions
14.09%
vs all stocks
Updated Aug 19, 2026
Total Cash (MRQ)
16.26BCNY
2.42B · vs all stocks (USD)
Updated Aug 19, 2026
Total Cash per Share (MRQ)
7.83CNYUpdated Aug 19, 2026
Total Debt (MRQ)
36.15BCNY
5.37B · vs all stocks (USD)
Updated Aug 19, 2026
Total Debt to Equity (MRQ)
0.7756x
Updated Aug 19, 2026
Current Ratio (MRQ)
0.9950x
Updated Aug 19, 2026
Book Value per Share (MRQ)
21.18CNYUpdated Aug 19, 2026
Total Assets
125.54BCNY
18.65B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
53.67BCNYFY2025 · Dec 31, 2025
Total Liabilities
80.57BCNYFY2025 · Dec 31, 2025
Total Non-current Assets
71.87BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
28.32BCNYFY2025 · Dec 31, 2025
Total Current Liabilities
52.25BCNYFY2025 · Dec 31, 2025
Cash
7.83BCNYFY2025 · Dec 31, 2025
Cash Equivalents
672.44MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
8.50BCNYFY2025 · Dec 31, 2025
Other Short-term Investments
7.79BCNYFY2025 · Dec 31, 2025
Accounts Receivable
14.86BCNYFY2025 · Dec 31, 2025
Inventory
8.24BCNYFY2025 · Dec 31, 2025
Accounts Payable
38.20BCNYFY2025 · Dec 31, 2025
Short-term Debt
7.25BCNYFY2025 · Dec 31, 2025
Other Current Liabilities
3.51BCNYFY2025 · Dec 31, 2025
Long-term Debt
25.81BCNYFY2025 · Dec 31, 2025
Common Stock (Book)
2.07BCNYFY2025 · Dec 31, 2025
Retained Earnings
19.41BCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
44.97BCNY
6.68B · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
47.11CNYUpdated Aug 19, 2026
52-Week High
94.44CNYUpdated Aug 19, 2026
52-Week Change
15.25%
vs all stocks
Updated Aug 19, 2026
Beta
0.7070x
vs all stocks
Updated Aug 19, 2026
50-Day MA
57.72CNYUpdated Aug 19, 2026
200-Day MA
65.45CNYUpdated Aug 19, 2026
Avg 10-Day Volume
41.61MSharesUpdated Aug 19, 2026
Avg 30-Day Volume
46.38MSharesUpdated Aug 19, 2026
Diluted EPS (TTM)
2.10CNYUpdated Aug 19, 2026
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Price Below Mean With Profitability And Book Value
Price sits well below its yearly mean, on three profitable years and rising book value.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 1.75: grey zoneSignificant
Altman Z-Score: 1.75
Supply Chain
Downstream position: depends on 11 industries, supplies 6Notable
Outgoing: 6.00Incoming: 11.00
High connectivity hub: 17 industry connectionsNotable
Total Connections: 17.00
Scale
Levered free cash flow is -$910.11M, lower than 95% of all stocks globallySignificant